Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
26.76B | 24.67B | 21.55B | 24.59B | 21.52B | 20.71B | Gross Profit |
5.65B | 4.65B | 3.91B | 5.00B | 3.92B | 3.71B | EBIT |
2.78B | 2.09B | 1.74B | 2.67B | 1.90B | 1.75B | EBITDA |
3.06B | 2.52B | 2.00B | 2.93B | 2.15B | 2.00B | Net Income Common Stockholders |
2.02B | 1.55B | 999.00M | 1.97B | 1.33B | 1.22B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.20B | 8.36B | 7.63B | 5.57B | 6.44B | 4.75B | Total Assets |
33.80B | 34.64B | 30.16B | 29.52B | 29.73B | 26.08B | Total Debt |
1.68B | 1.63B | 1.38B | 1.73B | 1.55B | 1.51B | Net Debt |
-6.51B | -6.73B | -6.25B | -3.84B | -4.89B | -3.24B | Total Liabilities |
15.45B | 17.19B | 14.73B | 14.83B | 16.46B | 14.32B | Stockholders Equity |
18.35B | 17.45B | 15.42B | 14.69B | 13.27B | 11.76B |
Cash Flow | Free Cash Flow | ||||
0.00 | 774.00M | 2.81B | -363.00M | 1.94B | -1.90B | Operating Cash Flow |
0.00 | 1.01B | 3.41B | -214.00M | 2.12B | -1.72B | Investing Cash Flow |
0.00 | -234.00M | -589.00M | -150.00M | -186.00M | -177.00M | Financing Cash Flow |
0.00 | -79.00M | -770.00M | -518.00M | -260.00M | -73.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥19.00B | 7.79 | 5.12% | 16.52% | 39.65% | ||
78 Outperform | ¥17.93B | 7.72 | 4.55% | 7.14% | 48.60% | ||
74 Outperform | ¥88.60B | 12.33 | 2.54% | 17.01% | 16.10% | ||
72 Outperform | ¥20.19B | 7.96 | 5.01% | -4.51% | -4.46% | ||
67 Neutral | ¥22.05B | 24.44 | 6.15% | 3.00% | -62.95% | ||
67 Neutral | ¥92.50B | 17.52 | 5.31% | 0.68% | -32.89% | ||
66 Neutral | $4.46B | 12.11 | 5.38% | 5.02% | 4.17% | -11.82% |